ID

41452

Descripción

Study ID: 107671 Clinical Study ID: 107671 Study Title: EGF107671 – A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00437073 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: N/A Trade Name: capecitabine, topotecan, lapatinib Study Indication: Neoplasms, Breast; Recurrent Brain Metastases

Palabras clave

Versiones (1)
  1. 13/10/20 13/10/20 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

13 de octubre de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Lapatinib + Topotecan or + Capecitabine in Recurrent Brain Metastases from Breast Cancer; NCT00437073

Inglés

Survival Follow-Up

1 formularios  
  1. StudyEvent: ODM
    1. Survival Follow-Up
Date of Visit/Assessment
Descripción

Date of Visit/Assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Descripción

Date of visit; Assessment Date

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
UMLS CUI [2]
C2985720
Survival Follow-Up
Descripción

Survival Follow-Up

Alias
UMLS CUI-1
C1522577
UMLS CUI-2
C0038952
Is the subject alive?
Descripción

Alive (finding)

Tipo de datos

text

Alias
UMLS CUI [1]
C2584946
Date of Contact
Descripción

Alive (finding), Date last contact

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2584946
UMLS CUI [1,2]
C0805839
Has the subject started any new anti-cancer therapy since the last contact?
Descripción

Cancer treatment, New

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205314
Yes, Start Date
Descripción

Cancer treatment, New, Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205314
UMLS CUI [1,3]
C0808070
Volver a la parte superior de la página

Similar models

Survival Follow-Up

1 formularios
  1. StudyEvent: ODM
    1. Survival Follow-Up
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Date of Visit/Assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit; Assessment Date
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
C2985720 (UMLS CUI [2])
Item Group
Survival Follow-Up
C1522577 (UMLS CUI-1)
C0038952 (UMLS CUI-2)
Item
Is the subject alive?
text
C2584946 (UMLS CUI [1])
Level of consciousness
Code List
Is the subject alive?
CL Item
Yes, complete Date of Contact (1)
CL Item
No, complete Death and Study Conclusion forms (2)
Alive (finding), Date last contact
Item
Date of Contact
date
C2584946 (UMLS CUI [1,1])
C0805839 (UMLS CUI [1,2])
Item
Has the subject started any new anti-cancer therapy since the last contact?
text
C0920425 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
Cancer treatment, New
Code List
Has the subject started any new anti-cancer therapy since the last contact?
CL Item
Yes, complete Start Date (1)
CL Item
No (2)
Cancer treatment, New, Start Date
Item
Yes, Start Date
date
C0920425 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial